Foresta Adds Japanese Patent as Kawerau Project Clears Design Milestone

Japanese Patent Adds Protection for Pine Chemical Process

Foresta Group Holdings Limited (ASX:FGH) has secured acceptance in Japan for a patent covering parts of its proprietary rosin and terpene extraction technology, giving the company another piece of intellectual property to support its planned pine chemicals business.

The accepted application covers extraction methods using a rotary extractor under specified operating conditions. Foresta is also progressing a divisional Japanese application covering the counter-current treatment of wood with a terpene-based extraction agent, while pursuing related claim scope in Europe and China. The development builds on the company’s US patent allowance, reported in July, and leaves the commercial value of the broader patent portfolio dependent on project execution and eventual market adoption.

Kawerau Moves Through Initial Design Gate

At Kawerau, Foresta says it completed Front-End Loading 1 concept design activities and finalised Class 5 capital cost estimates for the Stage 1 project. Operating cost work, financial modelling and programme modelling continued during the quarter, but the company did not disclose the resulting CAPEX, OPEX or production estimates.

The company is preparing for the next development phase with a staged procurement strategy that includes equipment supplier engagement and early contractor involvement. It is also assessing geothermal heat suppliers, main and backup power connections, and the infrastructure needed to support the project. The work follows the 30-year Kawerau lease secured earlier this year, although the current report does not announce a final investment decision, construction start or binding customer agreement.

Feedstock Study Tests Radiata Pine Opportunity

Foresta has entered a collaboration agreement with the Bioeconomy Science Institute to measure and characterise rosin and turpentine extractives in radiata pine stems, stumps and branches from different growing regions. The NZ$150,050 project is supported by the Bioresource Processing Alliance, which will contribute NZ$54,150, matching Foresta’s cash contribution; Foresta will provide a further NZ$41,750 in-kind.

The research is intended to establish the concentration, composition and variability of the relevant extractives. That should give Foresta better feedstock data for assessing its pine chemicals project, but it remains a research input rather than evidence of commercial production or contracted supply.

Cash Runway Narrows Before FEL 2

Foresta reported $2.472 million in cash at 30 September, against net operating cash use of $933,000 for the quarter. On that basis, the company calculated an estimated 2.65 quarters of funding available, with no unused finance facilities. It also has $2 million of convertible notes outstanding, carrying capitalised interest at 10% a year and maturing on 31 March 2028.

Related-party payments totalled $271,234 for the quarter, comprising executive director fees, executive consulting fees and non-executive director fees. The immediate tension is straightforward: Foresta is adding technical definition, infrastructure work and feedstock research to a project that has not yet reached FEL 2, while its reported cash cover is measured in quarters rather than years. The next material test will be whether updated project economics and financing arrangements emerge before that runway becomes binding.